RecruitingACTRN12618000178246

Coronary and Peripheral Haemodynamic Studies of Angina with No Obstructive Coronary Artery Disease - association between invasive and non-invasive investigation modalities.

Coronary and Peripheral Haemodynamic Studies of Angina with No Obstructive Coronary Artery Disease.


Sponsor

University of Adelaide

Enrollment

60 participants

Start Date

Feb 1, 2018

Study Type

Observational

Conditions

Summary

About 20-30% of patients with angina have no obstructive coronary artery disease on coronary angiogram (NoCAD). Despite no significant obstructive coronary artery disease, most of these patients continue to experience recurrent chest pain without any definitive diagnosis. Comprehensive invasive coronary haemodynamic studies at the time of diagnostic coronary angiogram will provide important diagnostic and prognostic implications for the management of coronary vasomotor disorder, but routine assessment is difficult. The hyperaemic microvascular resistance (HMR) is a reliable but invasive measure to assess coronary microvascular function. The planned project will evaluate whether left ventricular contractile reserve (CR), measured with strain imaging on low dose dobutamine stress echocardiography (DSE), is a reliable non-invasive measure of coronary microvascular function.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 80 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at chest pain (angina) in people whose coronary arteries appear normal or nearly normal on a heart scan — a condition called angina with no obstructive coronary artery disease (NoCAD). Despite having no major blockages, many of these patients continue having chest pain. The study will use invasive and non-invasive heart tests to understand whether problems with tiny heart blood vessels (microvascular disease) are causing the symptoms, and whether a non-invasive ultrasound test (stress echocardiography) can reliably detect these problems. You may be eligible if: - You are aged 18 to 80 years - You have been clinically diagnosed with angina (chest pain) - You have ongoing (persistent) angina symptoms - Your coronary angiogram shows no significant blockages (less than 50% narrowing) You may NOT be eligible if: - You had an acute heart attack or coronary syndrome within the past month - You have had coronary artery bypass surgery - You have a pacemaker or defibrillator - You have severe kidney or liver disease, severe asthma, or weak heart function (ejection fraction below 50%) - Your chest pain is caused by an identified blockage or other structural heart condition Talk to your doctor about whether this trial might be right for you.

This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Patients with angina and no obstructive coronary artery disease on invasive diagnostic coronary angiography will undergo comprehensive invasive coronary haemodynamic studies at the time of procedure t

Patients with angina and no obstructive coronary artery disease on invasive diagnostic coronary angiography will undergo comprehensive invasive coronary haemodynamic studies at the time of procedure to evaluate possible coronary vasomotor disorder leading to patient's symptoms. Haemodynamic studies will include the assessment of resting angiographic contrast flow, coronary microvascular hyperaemic function, coronary endothelial function and provocative coronary spasm testing. This comprehensive testing will add 30-45 minutes to the diagnostic coronary angiography procedure. The invasive parameters will be analysed and correlate with non-invasive assessment of contractile reserve obtained from low dose dobutamine stress echocardiography technique, pulse waveform analysis parameters and retinal artery changes.


Locations(1)

Lyell McEwin Hospital - Elizabeth Vale

SA, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12618000178246


Related Trials